Stay informed!
You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?
Subscribe to our free GMP Newsletter LOGFILE!
Award for the
GMP Compliance Adviser
GMP knowledge that convinces.
On 7 June 2016 Maas & Peither GMP Publishing has received a
"Best New Success Story" and was awarded with the 3rd place.
The GMP MANUAL (now: GMP Compliance Adviser) impressed the jury with "Save Drugs through Better GMP Understanding".
GMP Compliance Adviser (formerly GMP MANUAL)
GMP in Practice: 24 chapters written by internationally renowned industry experts.
GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.
TOP 5 GMP Downloads
1. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.
2. Questionnaire for preparing GMP-inspections
More than 650 typical questions related to audits and inspections.
3. GDP Audit Checklist
More than 700 questions with reference to regulations.
4. The New USP <1231>: Water for Pharmaceutical Purposes
A detailed overview
5. GMP Compliance Basics of Packaging Materials and Processes
Are you on top of the best practices you need to design and create your packaging correctly — every time?
News about GMP/cGMP
EMEA: Announcement of European Medicines Agency priorities for adverse drug reaction research
The priorities were developed with a view to them being considered as future topics for the 4th Call of the European Commission's Framework Program (FP7).
On 30 July 2009, the Commission published several calls for proposals of FP7 including three calls under the ‘Health’ Theme. The priorities for adverse drug reaction research are reflected in the call ‘FP7-HEALTH-2010-single-stage’, call topic HEALTH.210.4.2-3, Adverse drug reaction research and the European Medicines Agency now wishes to release complementary information with the aim to support researchers in developing proposals that meet the needs of the respective selected research area (please see links below).
Proposals to the call topic HEALTH.2010.4.2-3: Adverse drug reaction research should address one of the below areas and more than one project might be funded.
Further information on the FP7 calls and specifically on the call ‘FP7-HEALTH-2010-single-stage’ can be found at http://cordis.europa.eu/fetch?CALLER=FP7_NEWS&ACTION=D&RCN=31090 and http://cordis.europa.eu/fp7/dc/index.cfm?fuseaction=UserSite.CooperationDetailsCallPage&call_id=278
Source: EMEA News Release, AUG 2009